nonbuffered lidocaine
PreclinicalSmall molecule
nonbuffered lidocaine is one of 13 small molecule programs targeting Toothache. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
12
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
12 competitors in Toothache
#DrugCompanyPhaseTrials
1Bayer Aspirin
BayerApproved
Aleve
Jazz PharmaceuticalsApproved
Epidiolex
Jazz PharmaceuticalsApproved
Voltaren
NovartisApproved
Marcaine
IInnocoll
Approved
Indocin
CCosette Pharmaceuticals, Inc.
Approved
Celebrex
PPhiladelphia Eye Associates
Approved
Tylenol
KKenvue Brands
Approved
Oxycontin
PProtega
Approved
Advil
KKenvue Brands
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for nonbuffered lidocaine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- OOhio State University